Obecabtagene autoleucel (obe-cel) Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since July 2026

Pipeline

Phase 1: 1

Top Sponsors

Autolus Limited1

Indications

Progressive Multiple Sclerosis1
Multiple Sclerosis1

Redwood City, California1 trial

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Stanford University

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.